Skip to content

Clinical trials

Mucopolysaccharidosis II trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20081
20092
20101
20121
20131
20143
20151
20171
20191
20202
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting4
Available1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire11
Denali Therapeutics Inc.4
Takeda2
JCR Pharmaceuticals Co., Ltd.1
Manchester University NHS Foundation Trust1
REGENXBIO Inc.1
University of Manchester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II21
Sudden Infant Death12
Lysosomal Storage Diseases7
Mucopolysaccharidoses3
Cognitive Dysfunction1
Margins of Excision1
Mucopolysaccharidosis I1
Mucopolysaccharidosis III1
Mucopolysaccharidosis VI1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.